← All organizations

Generex Biotechnology Corp.

For profitWebsite ↗

Also known as: Antigen Express, Inc | Antigen Express, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

May 3, 2019

Timeline

1980s

Jun 1, 1983
Generex Biotechnology Corp.— Founded

2010s

Jun 25, 2019
Kiromic, LLC— Acquired

Drugs by trial phase (10 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

insulin human

Phase 2 (5 own, 4 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Kiromic, LLC

Recent trials (6)

NCT04024800Lead sponsorPhase 2May 3, 2019
NCT00948493Lead sponsorN/AJul 27, 2009
NCT00668850Study directorPhase 3Apr 1, 2008
NCT00668850Study chairPhase 3Apr 1, 2008
NCT00668850Lead sponsorPhase 3Apr 1, 2008
NCT00524277CollaboratorPhase 2Jan 1, 2007

Details

Founded: Toronto, ON, CA Jun 1, 1983
Last known activity: May 3, 2019